Counteracting Structural Barriers to Increase Access to Medications for Opioid Use Disorder (MOUD) Among Unhoused Montanans

消除结构性障碍,增加无家可归的蒙大拿人获得阿片类药物使用障碍 (MOUD) 药物的机会

基本信息

  • 批准号:
    10773710
  • 负责人:
  • 金额:
    $ 112.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-22 至 2028-09-21
  • 项目状态:
    未结题

项目摘要

The opioid epidemic has disproportionately impacted the unhoused population with an overdose death rate 20 times higher than that of the general population. Medications for opioid use disorder (MOUD) is highly effective in saving lives, but unhoused individuals experience many structural barriers to accessing treatment – stigmatization by healthcare providers, limited acceptance of Medicaid, and personal instability that precludes treatment co-requirements. Those barriers are compounded for unhoused individuals in Montana (MT) where the number of Montanans with opioid use disorder (OUD) outweigh treatment capacity by 10-fold with 92% of individuals with OUD (housed and unhoused) not receiving treatment. To combat these barriers, we will utilize three evidence-based interventions proven to increase engagement of underserved populations: 1) MOUD care based in syringe service programs (SSPs), 2) a nurse-led model of MOUD, and 3) peer navigator supported care. We will embed these interventions into the five SSPs that span the state of MT – sites located in both urban and rural areas with three sites adjacent to American Indian Reservations. Following the OUD cascade of care framework, we will assess the following measures among SSP clients: 1) engaged in care services at SSP, 2) OUD diagnosis by SSP prescriber, 3) MOUD initiations, 4) patient days on MOUD, and 5) MOUD for ≥ 60 days, 90 days, and 180 days. In each SSP, we aim to surpass the state average of Montanans utilizing MOUD. In whole, we intend to make these SSPs the state model for equitable OUD care.
阿片类药物的流行对无住房人口造成了不成比例的影响,导致过量死亡

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Rebecca Ramos其他文献

Rebecca Ramos的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似海外基金

An innovative urinary drainage system that could reduce NHS CAUTI treatment costs by 10% and increase quality-of-life for men suffering from chronic incontinence
%20创新%20泌尿%20引流%20系统%20%20可以%20减少%20NHS%20CAUTI%20治疗%20成本%20by%2010%%20和%20增加%20生活质量%20为%20男性%20痛苦%20来自%20慢性%20失禁
  • 批准号:
    10094849
  • 财政年份:
    2024
  • 资助金额:
    $ 112.42万
  • 项目类别:
    Collaborative R&D
Pulmonary rehabilitation delivered in low resource settings for people with chronic respiratory disease: a 3-arm assessor-blind implementation trial
在资源匮乏的环境中为慢性呼吸道疾病患者提供肺康复:一项三臂评估者盲法实施试验
  • 批准号:
    MR/Y004809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 112.42万
  • 项目类别:
    Research Grant
PFI-TT: A Novel Wireless Sensor for Continuous Monitoring of Patients with Chronic Diseases
PFI-TT:一种用于持续监测慢性病患者的新型无线传感器
  • 批准号:
    2345803
  • 财政年份:
    2024
  • 资助金额:
    $ 112.42万
  • 项目类别:
    Continuing Grant
Does chronic thyroid inflammation explain persistent symptoms in Hashimoto thyroiditis?
慢性甲状腺炎症是否可以解释桥本甲状腺炎的持续症状?
  • 批准号:
    MR/Z503617/1
  • 财政年份:
    2024
  • 资助金额:
    $ 112.42万
  • 项目类别:
    Research Grant
ICF: A novel dual-target gene therapy for safe and efficacious treatment of chronic non-infectious uveitis
ICF:一种安全有效治疗慢性非感染性葡萄膜炎的新型双靶点基因疗法
  • 批准号:
    MR/Z50385X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 112.42万
  • 项目类别:
    Research Grant
Inequality, infections and chronic disease in England: the interaction of risk factors and the dynamics of transmission
英国的不平等、感染和慢性病:危险因素和传播动态的相互作用
  • 批准号:
    MR/X033260/1
  • 财政年份:
    2024
  • 资助金额:
    $ 112.42万
  • 项目类别:
    Fellowship
The role of LILRB3-mediated immunomodulation on myeloid cells and exploration of new combination therapy for chronic inflammation and cancer
LILRB3介导的免疫调节对骨髓细胞的作用及慢性炎症和癌症联合治疗的探索
  • 批准号:
    24K18478
  • 财政年份:
    2024
  • 资助金额:
    $ 112.42万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Healthy Jozi: A Staged Approach to Better Workplace Food Choices and Chronic Disease Screening and Linkage to Care
健康 Jozi:更好的工作场所食物选择和慢性病筛查以及与护理联系的分阶段方法
  • 批准号:
    MR/Z000467/1
  • 财政年份:
    2024
  • 资助金额:
    $ 112.42万
  • 项目类别:
    Research Grant
Cellular dynamics in chronic lung disease: the neglected B cell axis
慢性肺病的细胞动力学:被忽视的 B 细胞轴
  • 批准号:
    MR/X03383X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 112.42万
  • 项目类别:
    Fellowship
CAREER: A Multi-phase Biosensing Approach towards Point-of-Care Evaluation of Pseudomonas aeruginosa Virulence in Infected Chronic Wounds
职业生涯:用于护理点评估慢性感染伤口中铜绿假单胞菌毒力的多阶段生物传感方法
  • 批准号:
    2340867
  • 财政年份:
    2024
  • 资助金额:
    $ 112.42万
  • 项目类别:
    Continuing Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了